InvestorsHub Logo
Followers 8
Posts 450
Boards Moderated 0
Alias Born 10/04/2010

Re: gss2003 post# 2475

Wednesday, 09/28/2016 11:18:33 AM

Wednesday, September 28, 2016 11:18:33 AM

Post# of 3835
They have good data from the Phase 1 for the Alpha 2 Macroglobulin biomarker that has a strong connection to tracking the development of fibrosis and cirrhosis plus all the animal trials have been really good, I'd rather base the future of the company on that than a pipedream of success in cancer therapy.

They will have interim results (whether published or private) by the end of March, that's probably the reason why they gave Shlevin and the CFO those bonuses (which really piss me off).

I have virtually no faith in the GALT management team after this latest fiasco but it really doesn't matter at this point in time, the drug will either work or it won't work. If it works the shares will be much higher, if it doesn't work they will be $0 and that will be a well deserved valuation
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News